Market Overview

Kindred Up 6%; Susquehanna Sees 'Cleaner Path' For Gentiva Bid


Kindred Healthcare (NYSE: KND) gained nearly six percent Tuesday on speculation that its hopes to acquire Gentiva Health Services (NASDAQ: GTIV) are getting more realistic.

Gentiva has two offers of $17.25 on the table: one from Kindred and one from an unnamed bidder widely believed to be Formation Capital, an investment management firm that owns Genesis HealthCare.

Genesis agreed Monday to merge with Skilled Healthcare (NYSE: SKH) in a stock swap. Susquehanna analyst Chris Rigg said it's unlikely that Formation Capital can pursue two major and complex deals at the same time.

Rigg said the Genesis deal "creates a cleaner path" for Kindred's bid on Gentiva.

Gentiva fell 2.5 percent Tuesday to 18.35 per share, while Kindred traded up 5.6 percent to $21.31.

Latest Ratings for KND

Nov 2017Stifel NicolausUpgradesSellHold
Sep 2017Bank of AmericaMaintainsUnderperform
Aug 2017Deutsche BankMaintainsBuy

View More Analyst Ratings for KND
View the Latest Analyst Ratings


Related Articles (GTIV + KND)

View Comments and Join the Discussion!

Posted-In: Analyst Color M&A News Hot Intraday Update Analyst Ratings

Latest Ratings

IBIOCantor FitzgeraldInitiates Coverage On3.0
UPLDCanaccord GenuityMaintains57.0
EJefferiesInitiates Coverage On
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at